Preprint Review Version 2 Preserved in Portico This version is not peer-reviewed

From Normal to Pathological in Epidermal Compounds

Version 1 : Received: 8 January 2024 / Approved: 9 January 2024 / Online: 9 January 2024 (10:32:50 CET)
Version 2 : Received: 14 January 2024 / Approved: 15 January 2024 / Online: 15 January 2024 (15:35:53 CET)
Version 3 : Received: 12 February 2024 / Approved: 12 February 2024 / Online: 12 February 2024 (16:40:16 CET)

How to cite: CHESCA, A. From Normal to Pathological in Epidermal Compounds. Preprints 2024, 2024010665. https://doi.org/10.20944/preprints202401.0665.v2 CHESCA, A. From Normal to Pathological in Epidermal Compounds. Preprints 2024, 2024010665. https://doi.org/10.20944/preprints202401.0665.v2

Abstract

The aim of the study is to identify structural characteristics of melanocytic nevi. In this context using microscope, could be possible a good describtion related melanocytic nevi, reffering to youth pacients.Knowing the risk factors, one of the research direction is to have in attention the management options for melanocytic nevi. In this direction, implication of an interprofessional team strategies is one of the proper condition. Future directions refers to preventive and prophylactic methods.

Keywords

epiderm, compounds, analyse, alterations, melanocytic nevi

Subject

Medicine and Pharmacology, Medicine and Pharmacology

Comments (1)

Comment 1
Received: 15 January 2024
Commenter: ANTONELLA CHESCA
Commenter's Conflict of Interests: Author
Comment: title, key words, little changes in the written text, references
+ Respond to this comment

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 1
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.